2017
DOI: 10.1093/humrep/dex301
|View full text |Cite
|
Sign up to set email alerts
|

Early first trimester uteroplacental flow and the progressive disintegration of spiral artery plugs: new insights from contrast-enhanced ultrasound and tissue histopathology

Abstract: This project was supported by the Oregon Health and Science University Knight Cardiovascular Institute, Center for Developmental Health and the Struble Foundation. There are no competing interests.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
112
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 132 publications
(114 citation statements)
references
References 35 publications
1
112
0
1
Order By: Relevance
“…Here, we provide evidence that platelet-derived factors impair placental βhCG synthesis. Although trophoblast plugs in uterine arteries obstruct maternal arterial blood flow to the developing placental chorionic tissue during the first trimester of human pregnancy, maternal platelets may pass through narrow intertrophoblastic gaps that have been suggested to enable initial microvascular flux by 7 weeks of gestation [1]. We show platelets on the surface of placental villi from 5 weeks gestation onwards, where they either adhered directly on the apical surface of the syncytiotrophoblast or on initial perivillous fibrinoid.…”
Section: Discussionmentioning
confidence: 71%
See 1 more Smart Citation
“…Here, we provide evidence that platelet-derived factors impair placental βhCG synthesis. Although trophoblast plugs in uterine arteries obstruct maternal arterial blood flow to the developing placental chorionic tissue during the first trimester of human pregnancy, maternal platelets may pass through narrow intertrophoblastic gaps that have been suggested to enable initial microvascular flux by 7 weeks of gestation [1]. We show platelets on the surface of placental villi from 5 weeks gestation onwards, where they either adhered directly on the apical surface of the syncytiotrophoblast or on initial perivillous fibrinoid.…”
Section: Discussionmentioning
confidence: 71%
“…Placental extravillous trophoblasts invade the maternal decidua, where they accumulate and form cellular plugs that obstruct maternal arterial blood flow to the developing placental villous tissue until the end of the first trimester of pregnancy. However, presence of loosely cohesive trophoblast plugs with clear capillary-sized channels with flow toward the intervillous space has been suggested to enable initial microvascular flux by 7 weeks of gestation [1]. These channels seem to be the first signs of subsequent plug disintegration and complete remodeling of maternal spiral arteries into wide-bore, lowresistance conduits.…”
Section: Introductionmentioning
confidence: 99%
“…It is known that the placenta can become infected by 9-12 weeks gestation and perhaps even earlier, when maternal blood first enters the intervillous space and begins to perfuse the placenta at 8-9 weeks gestation. [28][29][30] A recent modeling study used placental histopathology results, parity, and transmission intensity data to estimate that 63% of infections become established by the end of the first trimester, with the highest risk occurring at the end of the third month. 31 The risk of PM correlates with the frequency and parasite density of maternal P. falciparum infections during pregnancy, but even low-density infections (ie those that are detectable by sensitive PCR or LAMP tests but not blood smear) can result in placental infection.…”
Section: Risk Factors and Timing Of Placental Infectionmentioning
confidence: 99%
“…Furthermore, in experimental rat studies it appears SonoVue™ does not affect the permeability of the placental barrier, with no leakage of molecules observed [17]. The plugging of spiral arteries in the placenta has been previously investigated using another agent, Definity™ (Lantheus Medical Imaging, Billerica, MA) [18] with no reported deleterious effects. Another agent Levovist™ (Schering, Berlin) was also used successfully to observe twin-twin transfusion [13].…”
mentioning
confidence: 99%
“…Darüber hinaus zeigt sich in experimentellen Studien mit Ratten, dass SonoVue keinen Einfluss auf die Permeabilität der Plazentaschranke hat und dass keine austretenden Moleküle beobachtet wurden [17]. Das Plugging der Spiralarterien der Plazenta wurde zuvor mit einem anderen Agens, Definity™ (Lantheus Medical Imaging, Billerica, MA), untersucht [18], ohne dass schädliche Wirkungen berichtet wurden. Ein weiteres Mittel, Levovist™ (Schering, Berlin), wurde ebenfalls erfolgreich zur Beobachtung des fetofetalen Transfusionssyndroms eingesetzt [13].…”
unclassified